GovChime
Notice ID: 99693008436f47debdc6667e0b7e551dCombined Synopsis/Solicitation

75F40121Q00104 - Laser Diffraction System (Brand-Name or Equal)

Archived on August 21, 2021. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
5:00 PM UTC−04:00
Posted
July 29, 2021
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Place of performance
Saint Louis, MO, 63110
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75F40121Q00104
Notice ID
99693008436f47debdc6667e0b7e551d

Description

This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 as supplemented with FAR 13 and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-06. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION. A SEPARATE SOLICITATION DOCUMENT (I.E. STANDARD FORM) WILL NOT BE ISSUED. The solicitation number for this acquisition is RFQ-FDA- 75F40121Q00104 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation: 334516 Analytical Laboratory Instrument Manufacturing. The Small Business Size Standard is 1,000 employees. This is a brand-name or equal 100% Small Business Set-Aside RFQ. Simplified acquisition procedures will be utilized. The U. S Food & Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) requires one (1) SYMPATEC HELOS Laser Diffraction system or equal. Inquires Offerors must submit all questions concerning this solicitation in writing electronically to adam.powell@fda.hhs.gov. Questions must be received no later than August 3, 2021 5:00 p.m. Eastern Standard Time. Any responses to questions will be made in writing, without identification of the questioner, and will be included in an amendment to the solicitation. Even if provided in other form, only the question responses included in the amendment to the solicitation will govern performance of the contract. BACKGROUND INFORMATION The FDA Center for Drug Evaluation and Research (CDER) Office of Pharmaceutical Quality (OPQ) Office of Testing & Research (OTR) operates as an integrated testing and research FDA laboratory to develop scientific methods and tools to assess pharmaceutical quality issues and support the following core functions: standard, guidance, and policy development, pharmaceutical quality surveillance, quality assessment of regulatory submissions, and rapid response to public health emergencies. To fulfill its mission, OTRs Division of Complex Drug Analysis (DCDA) utilizes a Sympatec HELOS laser diffraction instrument. The instrument is approaching the end of its useful life and needs to be replaced. To facilitate Generic Drug User Fee Amendments (GDUFA) research, DCDA requires a laser diffraction system that provides faster processing, range combination capability, and new algorithm functionality. Note: Reference attachment titled, "FDA RFQ 75F40121Q00104," for complete combined synopsis solicitation.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75F40121Q00104
  1. Combined Synopsis
  1. Combined SynopsisCurrentJul 29, 2021

    75F40121Q00104 - Laser Diffraction System (Brand-Name or Equal)

    Notice 99693008436f47debdc6667e0b7e551d on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75F40121Q00104

Archive Date

Aug 21, 2021

Office Address

Beltsville, MD, 20705